x

Posted 16 March, 2021

ENZO BIOCHEM INC appointed new CEO

CEO Change detected for ticker NYSE:ENZ in a 8-K filed on 16 March, 2021.


  On March 15, 2021, Enzo Biochem, Inc. (the "Company") issued a press release announcing that Dr. Elazar Rabbani, Founder and CEO, will step down as CEO and transition to a scientific role with the Company once a qualified successor is identified and hired by the Board.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of ENZO BIOCHEM INC
Health Care/Life Sciences • Biotechnology
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in August 1976 and is headquartered in New York, NY.
Market Cap
$67.2M
View Company Details
ENZO BIOCHEM INC by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers


On March 15, 2021, Enzo Biochem, Inc. (the "Company") issued a press release announcing that Dr. Elazar Rabbani, Founder and CEO, will step down as CEO and transition to a scientific role with the Company once a qualified successor is identified and hired by the Board. Dr. Rabbani will remain as a Director of the Company. A copy of the press release is furnished as Exhibit 99.1 attached hereto and is incorporated by reference in its entirety into this item 5.02 of this Current Report on Form 8-K.